In NSCLC, miR-520a-3p as a tumor suppressor was downregulated, and its upregulation impeded tumor progression by regulating MAP3K2, HOXD8, and PI3K/AKT/mTOR pathways [17–19]. Here, MAP3K2 is linked to non-small cell lung carcinoma.